QQ客服 官方微博 反馈留言

	Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy
	Liao, Yuqian; Liao, Yulu; Li, Jun; Li, Junyu; Fan, Ying; Xu, Binghe
	2018
卷号	10页码:3801-3808
关键词	Aurora kinase TNBC polymorphism prognosis
ISSN号	1179-1322
DOI	10.2147/CMAR.S174735
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6353744
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Liao, Yuqian,Liao, Yulu,Li, Jun,et al. Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy[J],2018,10:3801-3808.
APA	Liao, Yuqian,Liao, Yulu,Li, Jun,Li, Junyu,Fan, Ying,&Xu, Binghe.(2018).Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy.,10,3801-3808.
MLA	Liao, Yuqian,et al."Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy".10(2018):3801-3808.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。